George Millen: Unscripted
Insightful analysis on the leaders, maneuvers, and strategies defining modern business.
GM
Editor
George Millen
About This Column
George Millen is a commentator and strategist who explores the intersection of corporate governance and financial performance. Transitioning from his deep dive into executive transitions, George now delivers daily dispatches on the broad forces driving global business - from the ethics of leadership to the mechanics of high-stakes restructuring. With a reputation for providing "the story behind the appointment," he offers a unique lens on how power shifts impact the bottom line. His writing is essential for any professional seeking to understand the forces truly shaping the future of the firm.
Displaying items 41-60 of 640 in total
Read full article
Sprocket’s AI Agent: A New Mandate for Corporate Cyber Defense
Read full article
Sparrow's Florida Gambit: Unlocking Billions or Monetizing Red Tape?
Read full article
Tsingke's Gambit: Orchestrating China's Nucleic Acid Revolution
Read full article
The Edge of Productivity: Syntiant and Vibe Redefine In-Office AI
Read full article
QXO's Financial Gambit: How a Bond Buyback Cements a $17B Mega-Merger
Read full article
Genelux's Viral Gambit: A New Blueprint to Defeat Resistant Ovarian Cancer
Read full article
The Business of Hope: A Firm's Real Estate Play for Pittsburgh's Recovery
Read full article
Packsize's Packaging Empire: Panotec Buy Signals Global Consolidation
Read full article
Parmigiano Reggiano's Gamble: From Italian Import to American Staple
Read full article
Beyond the Picket Fence: The True Cost of Underinsured American Homes
Read full article
Kestra IM's $5B Milestone: A Blueprint for Advisor-Centric Growth
Read full article
GE HealthCare Bets on Upgrades to Tackle Aging MedTech Infrastructure
Read full article
Cycurion's Body Cam Bet: A 'Non-Dilutive' Deal with a Dilution Asterisk
Read full article
Auto Shop Answers Taps Industry Veteran Stasch to Engineer Billion-Dollar Push
Read full article
Exosens' Czech Deal: A Win for Europe's ITAR-Free Defense Ambitions
Read full article
Clara Capital's New Platform Isn't Just Tech—It's a Full-Scale Ecosystem Play
Read full article
Beyond the Hype: The Corporate Mandate to Make AI Accountable
Read full article
Daiichi & AstraZeneca's Datroway Nears EU Approval in Major Cancer Win
Read full article
Husher's 2-Second Swap: A New Benchmark or a Regulatory Minefield?
Read full article
UCID: 1
